Lyophilized pharmaceutical compositions for vaginal delivery

Disclosed herein is a solid lyophilized vaginal dosage form that can have an effective amount of at least one active ingredient, a crystalline structure forming agent in an amount of about 5 wt. % to about 40 wt. %, based on the total weight of the lyophilized dosage form, and at least one polymeric...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: McLaughlin, Rosaleen Theresa, Masto, Emilie, Wong, Yik Teng, Barrat, Niamh, Banbury, Susan Gerrard, Garrett, Lisa
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator McLaughlin, Rosaleen Theresa
Masto, Emilie
Wong, Yik Teng
Barrat, Niamh
Banbury, Susan Gerrard
Garrett, Lisa
description Disclosed herein is a solid lyophilized vaginal dosage form that can have an effective amount of at least one active ingredient, a crystalline structure forming agent in an amount of about 5 wt. % to about 40 wt. %, based on the total weight of the lyophilized dosage form, and at least one polymeric mucoadhesive matrix forming agent. The dosage form can have a pH of about 4.0 to 5.0, and can disintegrate within 120 seconds after being contacted with a vaginal mucosa. A method of delivering an active ingredient to the vaginal mucosa using the disclosed solid dosage form is also described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11026883B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11026883B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11026883B23</originalsourceid><addsrcrecordid>eNrjZLDxqcwvyMjMyaxKTVEoyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzytWSMsvUihLTM_MA0qkpOZklqUWVfIwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTiAqBReakl8aHBhoYGRmYWFsZORsbEqAEAZgEw9Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Lyophilized pharmaceutical compositions for vaginal delivery</title><source>esp@cenet</source><creator>McLaughlin, Rosaleen Theresa ; Masto, Emilie ; Wong, Yik Teng ; Barrat, Niamh ; Banbury, Susan Gerrard ; Garrett, Lisa</creator><creatorcontrib>McLaughlin, Rosaleen Theresa ; Masto, Emilie ; Wong, Yik Teng ; Barrat, Niamh ; Banbury, Susan Gerrard ; Garrett, Lisa</creatorcontrib><description>Disclosed herein is a solid lyophilized vaginal dosage form that can have an effective amount of at least one active ingredient, a crystalline structure forming agent in an amount of about 5 wt. % to about 40 wt. %, based on the total weight of the lyophilized dosage form, and at least one polymeric mucoadhesive matrix forming agent. The dosage form can have a pH of about 4.0 to 5.0, and can disintegrate within 120 seconds after being contacted with a vaginal mucosa. A method of delivering an active ingredient to the vaginal mucosa using the disclosed solid dosage form is also described.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210608&amp;DB=EPODOC&amp;CC=US&amp;NR=11026883B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210608&amp;DB=EPODOC&amp;CC=US&amp;NR=11026883B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>McLaughlin, Rosaleen Theresa</creatorcontrib><creatorcontrib>Masto, Emilie</creatorcontrib><creatorcontrib>Wong, Yik Teng</creatorcontrib><creatorcontrib>Barrat, Niamh</creatorcontrib><creatorcontrib>Banbury, Susan Gerrard</creatorcontrib><creatorcontrib>Garrett, Lisa</creatorcontrib><title>Lyophilized pharmaceutical compositions for vaginal delivery</title><description>Disclosed herein is a solid lyophilized vaginal dosage form that can have an effective amount of at least one active ingredient, a crystalline structure forming agent in an amount of about 5 wt. % to about 40 wt. %, based on the total weight of the lyophilized dosage form, and at least one polymeric mucoadhesive matrix forming agent. The dosage form can have a pH of about 4.0 to 5.0, and can disintegrate within 120 seconds after being contacted with a vaginal mucosa. A method of delivering an active ingredient to the vaginal mucosa using the disclosed solid dosage form is also described.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDxqcwvyMjMyaxKTVEoyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzytWSMsvUihLTM_MA0qkpOZklqUWVfIwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTiAqBReakl8aHBhoYGRmYWFsZORsbEqAEAZgEw9Q</recordid><startdate>20210608</startdate><enddate>20210608</enddate><creator>McLaughlin, Rosaleen Theresa</creator><creator>Masto, Emilie</creator><creator>Wong, Yik Teng</creator><creator>Barrat, Niamh</creator><creator>Banbury, Susan Gerrard</creator><creator>Garrett, Lisa</creator><scope>EVB</scope></search><sort><creationdate>20210608</creationdate><title>Lyophilized pharmaceutical compositions for vaginal delivery</title><author>McLaughlin, Rosaleen Theresa ; Masto, Emilie ; Wong, Yik Teng ; Barrat, Niamh ; Banbury, Susan Gerrard ; Garrett, Lisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11026883B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>McLaughlin, Rosaleen Theresa</creatorcontrib><creatorcontrib>Masto, Emilie</creatorcontrib><creatorcontrib>Wong, Yik Teng</creatorcontrib><creatorcontrib>Barrat, Niamh</creatorcontrib><creatorcontrib>Banbury, Susan Gerrard</creatorcontrib><creatorcontrib>Garrett, Lisa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>McLaughlin, Rosaleen Theresa</au><au>Masto, Emilie</au><au>Wong, Yik Teng</au><au>Barrat, Niamh</au><au>Banbury, Susan Gerrard</au><au>Garrett, Lisa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Lyophilized pharmaceutical compositions for vaginal delivery</title><date>2021-06-08</date><risdate>2021</risdate><abstract>Disclosed herein is a solid lyophilized vaginal dosage form that can have an effective amount of at least one active ingredient, a crystalline structure forming agent in an amount of about 5 wt. % to about 40 wt. %, based on the total weight of the lyophilized dosage form, and at least one polymeric mucoadhesive matrix forming agent. The dosage form can have a pH of about 4.0 to 5.0, and can disintegrate within 120 seconds after being contacted with a vaginal mucosa. A method of delivering an active ingredient to the vaginal mucosa using the disclosed solid dosage form is also described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US11026883B2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Lyophilized pharmaceutical compositions for vaginal delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A13%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=McLaughlin,%20Rosaleen%20Theresa&rft.date=2021-06-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11026883B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true